{"result": "(\"entity\"<|>AMERICAN THYROID ASSOCIATION<|>ORGANIZATION<|>The American Thyroid Association is a professional organization that provides guidelines for the treatment of thyroid disorders, including hypothyroidism.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY<|>ORGANIZATION<|>The European Society for Paediatric Endocrinology is a professional organization that establishes guidelines for the treatment of endocrine disorders in children, including congenital hypothyroidism.)\n##\n(\"entity\"<|>CISTINOSIS<|>EVENT<|>Cystinosis is a rare autosomal recessive lysosomal storage disease characterized by the accumulation of cystine crystals in various organs, primarily affecting the kidneys and thyroid.)\n##\n(\"entity\"<|>LEVOTHYROXINE<|>EVENT<|>Levothyroxine is a medication used as a replacement therapy for hypothyroidism, recommended by the American Thyroid Association for treatment.)\n##\n(\"entity\"<|>HYPOTHYROIDISM<|>EVENT<|>Hypothyroidism is a condition where the thyroid gland does not produce enough thyroid hormones, which can be treated with levothyroxine.)\n##\n(\"entity\"<|>AMIODARONE<|>EVENT<|>Amiodarone is an antiarrhythmic drug that can cause thyroid dysfunction in 15-20% of cases due to its high iodine content.)\n##\n(\"relationship\"<|>AMERICAN THYROID ASSOCIATION<|>LEVOTHYROXINE<|>The American Thyroid Association recommends levothyroxine as the initial treatment for hypothyroidism.<|>8)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY<|>LEVOTHYROXINE<|>The European Society for Paediatric Endocrinology establishes guidelines for the use of levothyroxine in treating congenital hypothyroidism.<|>8)\n##\n(\"relationship\"<|>CISTINOSIS<|>HYPOTHYROIDISM<|>Cystinosis can lead to thyroid dysfunction, affecting up to 70% of patients with the disease.<|>6)\n##\n(\"relationship\"<|>AMIODARONE<|>HYPOTHYROIDISM<|>Amiodarone can induce both hypothyroidism and hyperthyroidism due to its iodine content.<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , et al. Nephropathic cystinosis: an international consensus\n                                                                                                                                     document. Nephrol Dial Transplant. 2014;29:iv87-94.\n        La cistinosis es una rara enfermedad autosómica recesiva de almacenamiento lisosomal                                       • Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the Treatment of Hypothyroidism. Prepared\n                                                                                                                                     by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24:1670-51.\n        cuyas principales manifestaciones clínicas tienen lugar a nivel renal, con afectación del                                  • Lucky AW, Howley PM, Megyesi K, Spielberg SP, Schulman JD, et al. Endocrine studies in cystinosis: compensated primary\n        túbulo renal por acumulación de cristales de cistina. Sin embargo, el acúmulo de estos                                       hypothyroidism. J Pediatr. 1977;91:204-10.\n                                                                                                                                   • Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev. 2001;22:240-54.\n        cristales de cistina también tiene lugar a nivel de otros órganos como el tiroides. Se ha des-                             • Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, et al. Environmental iodine intake and thyroid dysfunction\n        crito acúmulo de cistina en las células foliculares tiroideas causantes de fibrosis y atrofia                                during chronic amiodarone therapy. Ann Intern Med. 1984;101:28-34.\n                                                                                                                                   • Singh N, Weisler SL, Hershman JM. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid.\n        de estas, con disfunción tiroidea hasta en un 70% de los pacientes con esta enfermedad                                       2001;11:967-71.\n        (opción A correcta).\n        La amiodarona es un fármaco antiarrítmico, muy rico en yodo (37% de su peso), que pro-                                     En relación con el hipotiroidismo congénito, ¿cuál de las siguientes respuestas\n        duce disfunción tiroidea en un 15-20% de los casos. Puede inducir la aparición tanto de un                              7\n        hipotiroidismo como de un hipertiroidismo. La proporción de hipo/hipertiroidismo depende                                   es cierta?\n        fundamentalmente de la ingesta de yodo; el hipertiroidismo es relativamente más frecuen-                                   A. El tratamiento inicial de elección es la terapia combinada con levotiroxina (10-15 µg por\n        te en áreas deficientes en yodo y el hipotiroidismo, en áreas con aporte adecuado de yodo                                       kg de peso) y triyodotironina (3,125 µg cada 12 h).\n        (opción B falsa).                                                                                                          B. Se debe posponer el tratamiento sustitutivo hasta tener los resultados de las pruebas de\n        Una de las vías de metabolización de la T4 y T3 es su conjugación hepática con ácido                                            imagen, sobre todo las de medicina nuclear.\n        glucurónico, por lo que fármacos que aumentan la actividad de estas enzimas pueden au-                                     C. En los defectos de las deshalogenasas (codificadas por el gen IYD) puede aparecer bocio.\n        mentar la metabolización de las hormonas                       tiroideas y dar lugar a modificaciones en los               D.   La presencia de bocio descarta alteraciones en la proteína transportadora de yodo NIS\n        requerimientos de hormonas tiroideas. Entre estos fármacos figura la carbamacepina, por                                         (Na/I symporter).\n        lo  que    la Guía de práctica         clínica de la American Thyroid Association                     (ATA) recomienda\n        controlar los niveles de TSH en pacientes hipotiroideos que inicien tratamiento con este\n        fármaco. Así pues, la opción C es falsa.                                                                                   COMENTARIO\n                                                                                                                                   En relación con la primera opción a la pregunta, la Guía de la European Society for Paedia-\n                                                                                                                                   tric Endocrinology de 2014 (ESPE) establece que el fármaco de elección para el tratamiento\n                                                                                                                                   del hipotiroidismo congénito es la levotiroxina aislada. En efecto, aunque la T3 sea la hor-\n                                                                                                                                   mona biológicamente activa, no hay ninguna evidencia de que el tratamiento combinado\n                                                                                                                                   de T4 yT3 sea más efectivo que la T4 sola, por lo que se recomienda usar únicamente la T4\n                                                                                                                                   como tratamiento (opción A falsa).\n                                                                                                                                   El inicio temprano del tratamiento con levotiroxina, dentro de las dos primeras semanas\n                                                                                                                                   de vida, es crucial para un desarrollo neurológico normal y es un factor determinante para\n                                                                                                                                   que el niño afectado adquiera un desarrollo\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}